Related Experiment Video

Updated: May 16, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Antitumor properties of natural compounds and related molecules

Inmaculada Robles-Fernández1, Fernando Rodríguez-Serrano, Pablo J Álvarez

  • 1Institute of Biopathology and Regenerative Medicine IBIMER, University of Granada, 18071, Granada, Spain.

Recent Patents on Anti-Cancer Drug Discovery
|November 20, 2012
PubMed

Insights

Natural compounds show promise as novel cancer treatments, offering potential alternatives to traditional chemotherapy with limited efficacy. Research highlights their antitumor properties, mechanisms, and preventive capabilities.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Cancer is a leading cause of death globally, particularly in developing nations.
  • Tumorigenesis involves multiple genetic and epigenetic alterations leading to uncontrolled cell growth.
  • Current chemotherapy often has limited efficacy and high recurrence rates, necessitating new therapeutic strategies.

Purpose of the Study:

  • To review recent patents on natural compounds with antitumor properties.
  • To analyze the structure, mechanism of action, and molecular targets of these natural agents.
  • To identify natural compounds with potential cancer-preventive effects.

Main Methods:

  • Systematic review of patents detailing antitumor properties of natural compounds.
  • Analysis of scientific literature on plant, animal, and microorganism-derived molecules.
  • Evaluation of clinical trial data for promising natural agents.

Main Results:

  • Numerous natural compounds and their derivatives exhibit significant antitumor activity.
  • Identified diverse mechanisms of action, including targeting specific molecular pathways.
  • Several natural agents are in various stages of clinical trials, showing therapeutic potential.
  • Evidence suggests some natural compounds may prevent cancer development.

Conclusions:

  • Natural compounds represent a promising source for novel, effective, and selective anticancer drugs.
  • Further research and development of these agents could lead to improved cancer therapies.
  • Natural products offer a viable avenue for both treatment and prevention of cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.